Ideaya Biosciences (IDYA) PT Raised to $60 at Citi, 'still believe IDYA remains an attractive M&A target'
Tweet Send to a Friend
Citi analyst Yigal Nochomovitz raised the price target on Ideaya Biosciences (NASDAQ: IDYA) to $60.00 (from $40.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
